GKHT Medical Technology Co. Ltd. A

Guoke Hengtai released its 2026 interim report. Total operating revenue was 3.164 billion yuan, down 13.98% from the same period last year. Net profit attributable to the parent company was 10.7065 million yuan, down 79.45% year-on-year. Net cash inflow from operating activities was 302 million yuan, down 28.07% year-on-year. The company's latest asset-liability ratio was 60.08%, gross margin was 9.27%, ROE was 0.44%, and diluted earnings per share was 0.02 yuan. Total asset turnover was 0.50 times, and inventory turnover was 1.10 times. The number of shareholders was 15,400, and the top ten shareholders held 66.95% of total share capital.

Guoke Hengtai released its 2026 interim report, showing first-half net profit attributable to the parent of 10.71 million yuan, down 79.4% year on year. Operating revenue was 3.164 billion yuan, down 14.0% year on year. Net profit attributable to the parent after deducting non-recurring items was 990,000 yuan, down 97.9% year on year. Net operating cash flow was 302 million yuan, down 22.0% year on year. Earnings per share were 0.02 yuan. In the second quarter, operating revenue was 1.6 billion yuan, down 17.7% year on year, and net profit attributable to the parent was 9.46 million yuan, down 84.5% year on year. As of the end of the second quarter, total assets were 6.257 billion yuan, down 1.3% from the end of the previous year, and net assets attributable to the parent were 2.461 billion yuan, down 1.8% from the end of the previous year. The company said the decline was mainly affected by industry policy, market demand and the macroeconomic environment. The overall market size of the medical device distribution industry fell 12.78% year on year in the first half, and the company continued to implement its product structure adjustment strategy, proactively exiting some product lines with weaker profitability.

On the evening of July 12, multiple listed companies on the Shanghai and Shenzhen exchanges released important announcements. StarNeto clarified that its satellite communication business is unrelated to the breakthrough in sea recovery technology for the Long March 10B carrier rocket, and that revenue from new businesses such as the low-altitude economy accounts for less than 5%. Zhezhong Co., Ltd. cautioned that there is uncertainty in converting new orders signed in 2026 into revenue, and that revenue from its main business of complete switchgear has continued to decline. Juli Sling was fined 4.5 million yuan by the Hebei Securities Regulatory Bureau for misleading statements on an interactive platform. The controlling shareholder of Western Region Gold, Xinjiang Nonferrous Metals, plans to merge entirely with Xinjiang Geology and Mining Investment Group, with the actual controller remaining unchanged. In terms of earnings, Yuehai Feed's net profit for the first half of the year is expected to increase by 965.92% to 1302.52%, Ningbo Fubon is expected to increase by 416.54% to 519.85%, Shanshan Co., Ltd. is expected to increase by 262% to 334%, Sanyou Chemical is expected to increase by about 129%, Yalian Machinery's flash report shows net profit growth of 60.06%, Shengnuo Bio is expected to increase by 43.23% to 64.79%, and both Rundu Pharma and China Satellite are expected to turn losses into profits year-on-year. In addition, Taikang Life Insurance plans to reduce its stake in Guoke Hengtai by no more than 3%, and Hengtong Co., Ltd. plans to invest in a digital smart industrial park in Indonesia, with a planned investment of no more than 2 billion yuan.

GKHT Medical Technology announced that shareholder Taikang Life Insurance plans to reduce its stake by up to 4.67 million shares, or 1% of total equity, through centralized bidding, and up to 9.34 million shares, or 2% of total equity, through block trades, within three months after 15 trading days. The total reduction will not exceed 3% of the company's total share capital, driven by the shareholder's own asset allocation needs.